Povidone-iodine for treatment of adenoviral conjunctivitis: An in vitro study;Povidoniod zur behandlung von adenoviruskonjunktivitis: Eine in-vitro-studie

Klinische Monatsblatter fur Augenheilkunde

Volumn 223, Issue 5, 2006, Pages 349-352

  Monnerat, N ^a   Bossart, W ^b   Thiel, Michael A ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adenovirus; Conjunctivitis; Povidone iodine

Indexed keywords

POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ADENOVIRUS; CONFERENCE PAPER; CONTROLLED STUDY; COST OF ILLNESS; CYTOTOXICITY; DILUTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION CONTROL; VIRAL CONJUNCTIVITIS; ARTICLE; CELL LINE; CELL SURVIVAL; PATHOLOGY; TREATMENT OUTCOME; ULTRASTRUCTURE; VIROLOGY; VIRUS INFECTION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANTI-INFECTIVE AGENTS, LOCAL; CELL LINE; CELL SURVIVAL; CONJUNCTIVITIS, VIRAL; HUMANS; POVIDONE-IODINE; TREATMENT OUTCOME;

EID: 33745964376     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926633     Document Type: Conference Paper

References (11)

1. Darougar S, Grey RH, Thaker U et al. Clinical and epidemiological features of adenovirus keratokonjunktivits in London. Br J Ophthalmol 1983; 67: 1-7
2. Dawson CR, Sheppard J. Follicular conjunctivits. In: Tasman W, Jaeger EA (Hrsg). Duane's Clinical Ophthalmology. Philadelphia: Lippincott-Raven, 1995:4:2-8
3. Gordon YJ, Gordon RY, Romanowski EG et al. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 1993; 100: 1835-1840
4. Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 1995; 332:562-566
5. Isenberg SJ, Apt L, Yoshimori R et al. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 1985; 103 (9): 1340-1342
6. Lacey RW, Catto A. Action of povidone-iodine against methidllin-sensitive and -resistant cultures of Staphylococcus aureus. Postgrad Med J 1993;69:78-83
7. Piednoir E, Bureau-Chalot F, Merle C et al. Direct costs associated with a nosocomial outbreak of adenoviral conjunctivits infection in a long-term care institution. AMJ Infect Control 2002; 30: 407-410
8. Prince HN, Nonemaker WS, Norgard RC et al. Drug resistance studies with topical antiseptics. J Pharm Sci 1978; 67: 1629-1931
9. Wutzler P, Sauerbrei A, Klocking R et al. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Research 2002; 54: 89-97
10. Wutzler P, Sauerbrei A, Klocking R et al. Virucidal and chlamydicidal activities of eye drops with povidone-iodine liposome complex. Ophthalmic Research 2000; 32: 118-125
11. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986; 151: 400-406